Related Experiment Videos
Tenascin expression in lichen sclerosus
Y Soini1, R Pöllänen, H Autio-Harmainen
1Department of Pathology, University of Oulu, Oulu University Hospital, Finland.
Summary
Tenascin, a protein, is abnormally present in vulvar lichen sclerosus (LS), potentially contributing to disease development by damaging the basement membrane. This protein is synthesized by skin cells and blood vessel cells in affected areas.
Area of Science:
- Dermatology
- Pathology
- Molecular Biology
Background:
- Vulvar lichen sclerosus (LS) is a chronic inflammatory skin condition with poorly understood pathogenesis.
- Abnormal extracellular matrix deposition is implicated in the tissue remodeling seen in LS.
Purpose of the Study:
- To investigate the distribution and cellular origin of tenascin in vulvar lichen sclerosus.
- To assess the integrity of the epithelial basement membrane in LS.
- To explore the potential role of tenascin in LS pathogenesis.
Main Methods:
- Immunohistochemistry for tenascin and type IV collagen on 44 LS tissue samples.
- In situ hybridization for tenascin mRNA on 10 selected LS cases.
Main Results:
- Strong tenascin immunoreactivity was observed in LS, particularly in inflamed areas with edema.
- Basement membrane showed attenuation and discontinuity, assessed by type IV collagen staining.
- Tenascin mRNA was detected in basal keratinocytes, dermal fibroblasts, and endothelial cells.
Conclusions:
- Abnormal tenascin accumulation and synthesis in LS suggest its involvement in disease pathogenesis.
- Tenascin may contribute to matrix destruction and basement membrane damage in LS.
- Upregulation of tenascin synthesis may be mediated by growth factors like TGF-beta.